GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » E10

Daiichinkyo Co (TSE:4568) E10 : 円69.92 (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Daiichinkyo Co's adjusted earnings per share data for the three months ended in Sep. 2024 was 円32.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円69.92 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Daiichinkyo Co's average E10 Growth Rate was 17.90% per year. During the past 3 years, the average E10 Growth Rate was 10.40% per year. During the past 5 years, the average E10 Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Daiichinkyo Co was 10.40% per year. The lowest was -11.50% per year. And the median was 6.20% per year.

As of today (2024-12-12), Daiichinkyo Co's current stock price is 円4434.00. Daiichinkyo Co's E10 for the quarter that ended in Sep. 2024 was 円69.92. Daiichinkyo Co's Shiller PE Ratio of today is 63.42.

During the past 13 years, the highest Shiller PE Ratio of Daiichinkyo Co was 91.32. The lowest was 8.79. And the median was 55.66.


Daiichinkyo Co E10 Historical Data

The historical data trend for Daiichinkyo Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co E10 Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.16 47.39 50.99 55.04 63.83

Daiichinkyo Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.31 61.11 63.83 67.84 69.92

Competitive Comparison of Daiichinkyo Co's E10

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Shiller PE Ratio falls into.



Daiichinkyo Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=32.22/108.9000*108.9000
=32.220

Current CPI (Sep. 2024) = 108.9000.

Daiichinkyo Co Quarterly Data

per share eps CPI Adj_EPS
201412 24.527 97.900 27.283
201503 103.900 97.900 115.574
201506 16.553 98.400 18.319
201509 17.277 98.500 19.101
201512 19.483 98.100 21.628
201603 -13.603 97.900 -15.131
201606 14.897 98.100 16.537
201609 9.060 98.000 10.068
201612 19.613 98.400 21.706
201703 -17.060 98.100 -18.938
201706 14.617 98.500 16.160
201709 2.570 98.800 2.833
201712 19.267 99.400 21.108
201803 -6.083 99.200 -6.678
201806 12.297 99.200 13.499
201809 10.300 99.900 11.228
201812 17.860 99.700 19.508
201903 7.503 99.700 8.195
201906 22.257 99.800 24.286
201909 10.820 100.100 11.771
201912 35.860 100.500 38.857
202003 -2.680 100.300 -2.910
202006 16.360 99.900 17.834
202009 10.170 99.900 11.086
202012 12.410 99.300 13.610
202103 0.170 99.900 0.185
202106 18.360 99.500 20.095
202109 14.200 100.100 15.448
202112 16.600 100.100 18.059
202203 -14.270 101.100 -15.371
202206 9.830 101.800 10.516
202209 20.570 103.100 21.727
202212 14.800 104.100 15.482
202303 11.720 104.400 12.225
202306 29.720 105.200 30.765
202309 20.840 106.200 21.370
202312 34.690 106.800 35.372
202403 19.370 107.200 19.677
202406 44.570 108.200 44.858
202409 32.220 108.900 32.220

Add all the adjusted EPS together and divide 10 will get our e10.


Daiichinkyo Co  (TSE:4568) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Daiichinkyo Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4434.00/69.92
=63.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Daiichinkyo Co was 91.32. The lowest was 8.79. And the median was 55.66.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Daiichinkyo Co E10 Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co Business Description

Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co Headlines

No Headlines